RE:RE:RE:Boys, boysAs a fellow multi-year DM shareholder (just over 2.5yrs for me) I definitely respect your opinion Petro. But I struggle to understand why you don't feel the SP has performed well for you. That tells me you maybe didn't average down enough over 2019? Otherwise you should be sitting at 400% at a minimum. That's pretty damn good, even over the 3yr time period that you've been invested.
You're right about the SP move in April was directly related to the possibility of DM selling covid test kits. That's pretty obvious. While the HC approval for iONEBIO didn't materialize, they navigated this road block by gaining distribution rights to one which already had approvals. So I would argue the April hype did in fact materialize, just differently (kudos to management), which is why the SP has held up quite well. Would love for you tell me about another stock with comparable float that has touched $0.01 and maintained the gains that DM has. Most stocks never recover from penny land.
Bringing in big AI contracts (ones that will move the SP in a big way) takes time; we've known about this $40M co-bid for what 6 months? And we may not get the result for another 3 months? That's a long time for a small cap company to stay afloat, so god bless these covid sales that have bought them time, and a more respectable balance sheet without further dilution.
Petro67 wrote: Do you remember what was the reason it moved from 2-18 in April? If you don't I will explain. It was the news about application placed with HC for distribution of tests. That never materialized. But, it is important what happened thereafter. Namely USAF, Lotte, Samsung and US media. These are heavy hitters in comparison to test kits because they are pertaining to the core DM busimess, AI. But who knows about it in US, where true money is? Nobody. I did try to promote stock on a private financial blog that I have an honor to be on, but nobody is interested.
You probably don't know but NATO and Lotte projects were also part of DM curiculum in 2018 and 2019 but they also failed to move the stock.
So it looks like regardless of who is at the helm, AI is not moving this stock. And if you guys think that selling tests will catapult this company, then you are wrong.